The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function

被引:43
作者
Bove, Marilisa [1 ]
Cicero, Arrigo F. G. [1 ]
Borghi, Claudio [1 ]
机构
[1] Univ Bologna, Hypertens Res Unit, Med & Surg Sci Dept, Bologna, Italy
关键词
Xantine oxidase inhibitors; Hyperuricemia; Hypertension; Chronic kidney disease; SERUM URIC-ACID; NUTRITION EXAMINATION SURVEY; CHRONIC KIDNEY-DISEASE; INCIDENT HYPERTENSION; CELL-PROLIFERATION; NATIONAL-HEALTH; ALLOPURINOL; HYPERURICEMIA; RISK; PROGRESSION;
D O I
10.1007/s11906-017-0793-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several epidemiological studies have demonstrated the existence of a correlation between high serum uric acid (SUA) levels, hypertension, and chronic kidney disease (CKD). Xantine oxidase inhibitors (XOI) are the most powerful uric acid lowering drugs, with presumed beneficial effects on cardiovascular and renal system. The multifactorial mechanism linking hyperuricemia with cardiovascular and renal diseases involves both the SUA level and the xanthine oxidase (XO) activity. In this context, the clinical research has been recently focused at assessing the efficacy of urate-lowering drugs active on XO in patients with abnormal blood pressure values and renal dysfunction. The mechanism of action responsible for the beneficial effect of XOI has not completely elucidated, and long-term studies involving large population samples are needed. In particular, XOI could play an important role in the management of hypertension and CKD, especially in patients not entirely controlled by conventional therapies. In the present review, we summarize the results of recent clinical trials that largely support a positive effect of allopurinol and febuxostat on blood pressure, glomerular filtration rate (GFR), and serum creatinine in different populations of patients. Will these drugs be considered a reliable choice or alternative to currently used drugs for the hypertension and kidney failure treatment? The debate is open, but much evidence is accumulating and supporting this role.
引用
收藏
页数:6
相关论文
共 51 条
  • [1] The impact of insulin resistance on the kidney and vasculature
    Artunc, Ferruh
    Schleicher, Erwin
    Weigert, Cora
    Fritsche, Andreas
    Stefan, Norbert
    Haering, Hans-Ulrich
    [J]. NATURE REVIEWS NEPHROLOGY, 2016, 12 (12) : 721 - 737
  • [2] Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension
    Beattie, Catherine J.
    Fulton, Rachael L.
    Higgins, Peter
    Padmanabhan, Sandosh
    McCallum, Linsay
    Walters, Matthew R.
    Dominiczak, Anna F.
    Touyz, Rhian M.
    Dawson, Jesse
    [J]. HYPERTENSION, 2014, 64 (05) : 1102 - +
  • [3] Febuxostat compared with allopurinol in patients with hyperuricemia and gout
    Becker, MA
    Schumacher, HR
    Wortmann, RL
    MacDonald, PA
    Eustace, D
    Palo, WA
    Streit, J
    Joseph-Ridge, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2450 - 2461
  • [4] Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
    Berry, CE
    Hare, JM
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03): : 589 - 606
  • [5] Billiet Laura, 2014, ISRN Rheumatol, V2014, P852954, DOI 10.1155/2014/852954
  • [6] Serum Uric Acid and Cardiometabolic Disease Another Brick in the Wall?
    Borghi, Claudio
    Francesco, Arrigo
    Cicero, Giuseppe
    [J]. HYPERTENSION, 2017, 69 (06) : 1011 - 1013
  • [7] Serum uric acid and the risk of cardiovascular and renal disease
    Borghi, Claudio
    Rosei, Enrico Agabiti
    Bardin, Thomas
    Dawson, Jesse
    Dominiczak, Anna
    Kielstein, Jan T.
    Manolis, Athanasios J.
    Perez-Ruiz, Fernando
    Mancia, Giuseppe
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 (09) : 1729 - 1741
  • [8] Bove M, 2017, VASC HEALTH RISK MAN, V13, P23, DOI 10.2147/VHRM.S115080
  • [9] A Prediction Model for the Risk of Incident Chronic Kidney Disease
    Chien, Kuo-Liong
    Lin, Hung-Ju
    Lee, Bai-Chin
    Hsu, Hsiu-Ching
    Lee, Yuan-Teh
    Chen, Ming-Fong
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (09) : 836 - U82
  • [10] Prevalence of the metabolic syndrome in individuals with hyperuricemia
    Choi, Hyon K.
    Ford, Earl S.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2007, 120 (05) : 442 - 447